TherapeuticsMD (TXMD) Revenue (2011 - 2026)

TherapeuticsMD (TXMD) has reported Revenue for 16 consecutive years, with $869000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue fell 8.72% year-over-year to $869000.0; the trailing twelve-month figure through Jun 2026 stood at $3.3 million (up 27.78% YoY), and the FY2025 full-year result was $3.0 million, up 71.61% from the prior year.
• Revenue grew to $869000.0 in Q2 2026 per TXMD's latest filing, from $724000.0 in the prior quarter.
• Across five years, Revenue topped out at $68.6 million in Q4 2022 and bottomed at $53000.0 in Q3 2023.
• Historically, Revenue has averaged $4.3 million across 5 years, with a median of $524500.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Revenue tumbled 99.27% in 2023, then jumped 932.08% in 2024.
• Over 5 years, Revenue stood at $68.6 million in 2022, then sank by 99.27% to $502000.0 in 2023, then surged by 32.87% to $667000.0 in 2024, then surged by 33.88% to $893000.0 in 2025, then retreated by 2.69% to $869000.0 in 2026.
• According to Business Quant data, Revenue over the past three periods registered $869000.0, $724000.0, and $893000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.